KDIGO provided recommendations on SGLT2 inhibitors and nonsteroidal MRAs in patients with diabetes and CKD. van Norman M, Molony DA. Ann Intern Med 2023 May 2. doi: 10.7326/J23-0023.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

van Norman M, Molony DA. KDIGO provided recommendations on SGLT2 inhibitors and nonsteroidal MRAs in patients with diabetes and CKD. Ann Intern Med 2023 May 2. doi: 10.7326/J23-0023.
PMID: 37126811